| Zoetis (ZTS) |
United States |
$79.473B |
30.58 |
| Takeda Pharmaceutical (TAK) |
Japan |
$43.433B |
9.04 |
| Merck (MKKGY) |
Germany |
$20.989B |
22.91 |
| Astellas Pharma (ALPMY) |
Japan |
$20.286B |
18.68 |
| Sandoz Group AG (SDZNY) |
Switzerland |
$19.912B |
0.00 |
| United Therapeutics (UTHR) |
United States |
$17.877B |
17.59 |
| Summit Therapeutics (SMMT) |
United States |
$16.054B |
0.00 |
| Neurocrine Biosciences (NBIX) |
United States |
$12.876B |
34.09 |
| Shionogi (SGIOY) |
Japan |
$12.330B |
11.81 |
| Catalent (CTLT) |
United States |
$10.793B |
0.00 |
| Jazz Pharmaceuticals (JAZZ) |
Ireland |
$7.685B |
7.52 |
| Madrigal Pharmaceuticals (MDGL) |
United States |
$7.408B |
0.00 |
| Orion OYJ (ORINY) |
Finland |
$6.848B |
19.25 |
| Corcept Therapeutics (CORT) |
United States |
$6.188B |
46.87 |
| Ionis Pharmaceuticals (IONS) |
United States |
$6.139B |
0.00 |
| Crinetics Pharmaceuticals (CRNX) |
United States |
$4.803B |
0.00 |
| PTC Therapeutics (PTCT) |
United States |
$3.461B |
0.00 |
| AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$2.848B |
17.04 |
| Dyne Therapeutics (DYN) |
United States |
$2.824B |
0.00 |
| Catalyst Pharmaceuticals (CPRX) |
United States |
$2.797B |
12.68 |
| Arrowhead Pharmaceuticals (ARWR) |
United States |
$2.731B |
0.00 |
| Soleno Therapeutics (SLNO) |
United States |
$2.552B |
0.00 |
| NewAmsterdam Pharma (NAMS) |
Netherlands |
$2.213B |
0.00 |
| Recursion Pharmaceuticals (RXRX) |
United States |
$2.204B |
0.00 |
| Centessa Pharmaceuticals (CNTA) |
United Kingdom |
$1.896B |
0.00 |
| Harrow (HROW) |
United States |
$1.846B |
0.00 |
| Evotec AG (EVO) |
Germany |
$1.726B |
0.00 |
| Ocular Therapeutix (OCUL) |
United States |
$1.709B |
0.00 |
| BioCryst Pharmaceuticals (BCRX) |
United States |
$1.696B |
0.00 |
| ARS Pharmaceuticals (SPRY) |
United States |
$1.696B |
0.00 |
| Xencor (XNCR) |
United States |
$1.631B |
0.00 |
| Avadel Pharmaceuticals (AVDL) |
Ireland |
$1.569B |
0.00 |
| Indivior (INDV) |
United States |
$1.449B |
5.90 |
| Guardian Pharmacy Services (GRDN) |
United States |
$1.382B |
0.00 |
| Enliven Therapeutics (ELVN) |
United States |
$1.305B |
0.00 |
| Cassava Sciences (SAVA) |
United States |
$1.302B |
0.00 |
| Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$1.216B |
0.00 |
| Ardelyx (ARDX) |
United States |
$1.159B |
0.00 |
| Collegium Pharmaceutical (COLL) |
United States |
$1.038B |
5.67 |
| Bioventus (BVS) |
United States |
$1.007B |
31.90 |
| Relay Therapeutics (RLAY) |
United States |
$0.825B |
0.00 |
| USANA Health Sciences (USNA) |
United States |
$0.787B |
14.59 |
| Ironwood Pharmaceuticals (IRWD) |
United States |
$0.764B |
0.00 |
| Exscientia (EXAI) |
United Kingdom |
$0.757B |
0.00 |
| Cronos Group (CRON) |
Canada |
$0.753B |
0.00 |
| Tourmaline Bio (TRML) |
United States |
$0.726B |
0.00 |
| Korro Bio (KRRO) |
United States |
$0.683B |
0.00 |
| Savara (SVRA) |
United States |
$0.670B |
0.00 |
| ProKidney (PROK) |
United States |
$0.623B |
0.00 |
| Larimar Therapeutics (LRMR) |
United States |
$0.593B |
0.00 |
| Elite Pharmaceuticals (ELTP) |
United States |
$0.578B |
54.10 |
| OmniAb (OABI) |
United States |
$0.544B |
0.00 |
| Verve Therapeutics (VERV) |
United States |
$0.544B |
0.00 |
| Siga Technologies (SIGA) |
United States |
$0.538B |
6.28 |
| Silence Therapeutics (SLN) |
United Kingdom |
$0.525B |
0.00 |
| Altimmune (ALT) |
United States |
$0.522B |
0.00 |
| Esperion Therapeutics (ESPR) |
United States |
$0.497B |
0.00 |
| Xeris Biopharma Holdings (XERS) |
United States |
$0.489B |
0.00 |
| Amylyx Pharmaceuticals (AMLX) |
United States |
$0.482B |
0.00 |
| KalVista Pharmaceuticals (KALV) |
United States |
$0.479B |
0.00 |
| Zevra Therapeutics (ZVRA) |
United States |
$0.471B |
0.00 |
| Organogenesis (ORGO) |
United States |
$0.464B |
0.00 |
| Aquestive Therapeutics (AQST) |
United States |
$0.462B |
0.00 |
| Theravance Biopharma (TBPH) |
Cayman Islands |
$0.444B |
0.00 |
| Rigel Pharmaceuticals (RIGL) |
United States |
$0.439B |
178.21 |
| Akebia Therapeutics (AKBA) |
United States |
$0.434B |
0.00 |
| 4D Molecular Therapeutics (FDMT) |
United States |
$0.419B |
0.00 |
| Sage Therapeutics (SAGE) |
United States |
$0.385B |
0.00 |
| Lyell Immunopharma (LYEL) |
United States |
$0.338B |
0.00 |
| Aldeyra Therapeutics (ALDX) |
United States |
$0.327B |
0.00 |
| Nature's Sunshine Products (NATR) |
United States |
$0.322B |
19.15 |
| Avita Medical (RCEL) |
United States |
$0.320B |
0.00 |
| Pyxis Oncology (PYXS) |
United States |
$0.282B |
0.00 |
| Heron Therapeutics (HRTX) |
United States |
$0.279B |
0.00 |
| Lexeo Therapeutics (LXEO) |
United States |
$0.263B |
0.00 |
| Acrivon Therapeutics (ACRV) |
United States |
$0.255B |
0.00 |
| Nektar Therapeutics (NKTR) |
United States |
$0.253B |
0.00 |
| Enanta Pharmaceuticals (ENTA) |
United States |
$0.230B |
0.00 |
| Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.226B |
0.00 |
| Profound Medical (PROF) |
Canada |
$0.201B |
0.00 |
| Nanobiotix S.A (NBTX) |
France |
$0.191B |
0.00 |
| Aclaris Therapeutics (ACRS) |
United States |
$0.188B |
0.00 |
| MediWound (MDWD) |
Israel |
$0.188B |
0.00 |
| Incannex Healthcare (IXHL) |
Australia |
$0.187B |
0.00 |
| Galectin Therapeutics (GALT) |
United States |
$0.180B |
0.00 |
| Cardiol Therapeutics (CRDL) |
Canada |
$0.157B |
0.00 |
| CytoDyn (CYDY) |
United States |
$0.154B |
0.00 |
| Achieve Life Sciences (ACHV) |
Canada |
$0.154B |
0.00 |
| Context Therapeutics (CNTX) |
United States |
$0.153B |
0.00 |
| Telomir Pharmaceuticals (TELO) |
United States |
$0.130B |
0.00 |
| Century Therapeutics (IPSC) |
United States |
$0.125B |
0.00 |
| VAXART, INC (VXRT) |
United States |
$0.123B |
0.00 |
| Fractyl Health (GUTS) |
United States |
$0.120B |
0.00 |
| OptiNose (OPTN) |
United States |
$0.116B |
0.00 |
| Journey Medical (DERM) |
United States |
$0.116B |
0.00 |
| Karyopharm Therapeutics (KPTI) |
United States |
$0.116B |
0.00 |
| Innate Pharma SA (IPHYF) |
France |
$0.103B |
0.00 |
| Relmada Therapeutics (RLMD) |
United States |
$0.098B |
0.00 |
| Arch Biopartners (ACHFF) |
Canada |
$0.093B |
0.00 |
| Regulus Therapeutics (RGLS) |
United States |
$0.092B |
0.00 |
| PMV Pharmaceuticals (PMVP) |
United States |
$0.091B |
0.00 |
| Assertio Holdings (ASRT) |
United States |
$0.088B |
23.12 |
| Inotiv (NOTV) |
United States |
$0.087B |
0.00 |
| CASI Pharmaceuticals (CASI) |
China |
$0.086B |
0.00 |
| ElectroCore (ECOR) |
United States |
$0.086B |
0.00 |
| AlloVir (ALVR) |
United States |
$0.085B |
0.00 |
| Citius Pharmaceuticals (CTXR) |
United States |
$0.081B |
0.00 |
| ESSA Pharma (EPIX) |
Canada |
$0.079B |
0.00 |
| Metagenomi (MGX) |
United States |
$0.078B |
0.00 |
| Vivani Medical (VANI) |
United States |
$0.070B |
0.00 |
| Prelude Therapeutics (PRLD) |
United States |
$0.065B |
0.00 |
| Mural Oncology (MURA) |
Ireland |
$0.062B |
0.00 |
| Champions Oncology (CSBR) |
United States |
$0.061B |
0.00 |
| Gain Therapeutics (GANX) |
United States |
$0.055B |
0.00 |
| Nutriband (NTRB) |
United States |
$0.054B |
0.00 |
| Protara Therapeutics (TARA) |
United States |
$0.053B |
0.00 |
| Unicycive Therapeutics (UNCY) |
United States |
$0.050B |
0.00 |
| SCYNEXIS (SCYX) |
United States |
$0.049B |
0.00 |
| Rafael Holdings (RFL) |
United States |
$0.046B |
0.00 |
| VYNE Therapeutics (VYNE) |
United States |
$0.045B |
0.00 |
| Verrica Pharmaceuticals (VRCA) |
United States |
$0.044B |
0.00 |
| Carisma Therapeutics (CARM) |
United States |
$0.042B |
0.00 |
| DURECT (DRRX) |
United States |
$0.040B |
0.00 |
| BioLineRx (BLRX) |
Israel |
$0.036B |
0.00 |
| FibroGen (FGEN) |
United States |
$0.034B |
0.00 |
| MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.034B |
0.00 |
| Reviva Pharmaceuticals Holdings (RVPH) |
United States |
$0.033B |
0.00 |
| Oruka Therapeutics (ORKA) |
United States |
$0.032B |
0.00 |
| Iterum Therapeutics (ITRM) |
Ireland |
$0.032B |
0.00 |
| Surrozen (SRZN) |
United States |
$0.031B |
0.00 |
| Lipocine (LPCN) |
United States |
$0.029B |
0.00 |
| BioVie (BIVI) |
United States |
$0.028B |
0.00 |
| Tempest Therapeutics (TPST) |
United States |
$0.028B |
0.00 |
| Natural Alternatives (NAII) |
United States |
$0.027B |
0.00 |
| GlycoMimetics (GLYC) |
United States |
$0.027B |
0.00 |
| Enlivex Therapeutics (ENLV) |
Israel |
$0.026B |
0.00 |
| Inhibikase Therapeutics (IKT) |
United States |
$0.021B |
0.00 |
| MEI Pharma (MEIP) |
United States |
$0.021B |
0.73 |
| Tonix Pharmaceuticals Holding (TNXP) |
United States |
$0.019B |
0.00 |
| Marinus Pharmaceuticals (MRNS) |
United States |
$0.018B |
0.00 |
| TherapeuticsMD (TXMD) |
United States |
$0.018B |
0.00 |
| Lyra Therapeutics (LYRA) |
United States |
$0.017B |
0.00 |
| Cumberland Pharmaceuticals (CPIX) |
United States |
$0.017B |
0.00 |
| PolyPid (PYPD) |
Israel |
$0.017B |
0.00 |
| Cosmos Health (COSM) |
United States |
$0.016B |
0.00 |
| Minerva Neurosciences (NERV) |
United States |
$0.016B |
0.00 |
| Vivos Therapeutics (VVOS) |
United States |
$0.015B |
0.00 |
| NLS Pharmaceutics (NLSP) |
Switzerland |
$0.015B |
0.00 |
| Talphera (TLPH) |
United States |
$0.015B |
0.00 |
| Mannatech (MTEX) |
United States |
$0.015B |
0.00 |
| Scienture Holdings (SCNX) |
United States |
$0.014B |
0.00 |
| ProPhase Labs (PRPH) |
United States |
$0.014B |
0.00 |
| Avalo Therapeutics (AVTX) |
United States |
$0.014B |
0.00 |
| NRx Pharmaceuticals (NRXP) |
United States |
$0.014B |
0.00 |
| Nuvilex (PMCB) |
United States |
$0.014B |
0.00 |
| Indaptus Therapeutics (INDP) |
United States |
$0.012B |
0.00 |
| Addex Therapeutics (ADXN) |
Switzerland |
$0.011B |
0.00 |
| Kiora Pharmaceuticals (KPRX) |
United States |
$0.011B |
0.00 |
| Dominari Holdings (DOMH) |
United States |
$0.011B |
0.00 |
| Redhill Biopharma (RDHL) |
Israel |
$0.010B |
0.00 |
| Traws Pharma (TRAW) |
United States |
$0.010B |
0.00 |
| Conduit Pharmaceuticals (CDT) |
United States |
$0.010B |
0.00 |
| XTL Biopharmaceuticals (XTLB) |
Israel |
$0.010B |
0.00 |
| Jaguar Animal Health (JAGX) |
United States |
$0.009B |
0.00 |
| Viracta Therapeutics (VIRX) |
United States |
$0.007B |
0.00 |
| Plus Therapeutics (PSTV) |
United States |
$0.007B |
0.00 |
| TransCode Therapeutics (RNAZ) |
United States |
$0.007B |
0.00 |
| Aptorum Group (APM) |
United Kingdom |
$0.007B |
0.00 |
| Biomerica (BMRA) |
United States |
$0.007B |
0.00 |
| Xenetic Biosciences (XBIO) |
United States |
$0.006B |
0.00 |
| Klotho Neurosciences (KLTO) |
United States |
$0.006B |
0.00 |
| Mangoceuticals (MGRX) |
United States |
$0.005B |
0.00 |
| Sonoma Pharmaceuticals (SNOA) |
United States |
$0.004B |
0.00 |
| Ainos (AIMD) |
United States |
$0.004B |
0.00 |
| TNF Pharmaceuticals (TNFA) |
United States |
$0.004B |
0.00 |
| SHINECO (SISI) |
China |
$0.004B |
0.00 |
| Oncternal Therapeutics (ONCT) |
United States |
$0.004B |
0.00 |
| Heatwurx (PCSA) |
United States |
$0.004B |
0.00 |
| Shuttle Pharmaceuticals Holdings (SHPH) |
United States |
$0.003B |
0.00 |
| Alaunos Therapeutics (TCRT) |
United States |
$0.003B |
0.00 |
| InMed Pharmaceuticals (INM) |
Canada |
$0.003B |
0.00 |
| Quoin Pharmaceuticals (QNRX) |
United States |
$0.003B |
0.00 |
| Petros Pharmaceuticals (PTPI) |
United States |
$0.003B |
0.00 |
| Avenue Therapeutics (ATXI) |
United States |
$0.003B |
0.08 |
| XORTX Therapeutics (XRTX) |
Canada |
$0.003B |
0.00 |
| Clearmind Medicine (CMND) |
Canada |
$0.003B |
0.00 |
| SciSparc (SPRC) |
Israel |
$0.002B |
0.00 |
| Bio-Path Holdings (BPTH) |
United States |
$0.002B |
0.00 |
| Molecular Templates (MTEM) |
United States |
$0.002B |
0.00 |
| Phio Pharmaceuticals (PHIO) |
United States |
$0.002B |
0.00 |
| Salarius Pharmaceuticals (SLRX) |
United States |
$0.002B |
0.00 |
| China SXT Pharmaceuticals (SXTC) |
China |
$0.002B |
0.00 |
| Galmed Pharmaceuticals (GLMD) |
Israel |
$0.002B |
0.00 |
| 60 Degrees Pharmaceuticals (SXTP) |
United States |
$0.002B |
0.00 |
| Altamira Therapeutics (CYTO) |
Bermuda |
$0.002B |
0.00 |
| Aditxt (ADTX) |
United States |
$0.002B |
0.00 |
| Qualigen Therapeutics (QLGN) |
United States |
$0.001B |
0.00 |
| Universe Pharmaceuticals INC (UPC) |
China |
$0.001B |
0.00 |
| PainReform (PRFX) |
Israel |
$0.000B |
0.00 |
| CERo Therapeutics Holdings (CERO) |
United States |
$0.000B |
0.00 |
| Grifols, S.A (GRFS) |
Spain |
$0.000B |
0.00 |
| 4D Pharma (LBPS) |
United Kingdom |
$0.000B |
0.00 |
| Procaps Group, S.A (PROC) |
Luxembourg |
$0.000B |
2.98 |
| Patheon (PTHN) |
Netherlands |
$0.000B |
0.00 |
| RVL Pharmaceuticals (RVLP) |
United States |
$0.000B |
0.00 |
| Stevanato Group S.p.A (STVN) |
Italy |
$0.000B |
41.74 |
